Abiopharma

Wirk Shaheen 🟢 acquired 6.0K shares of Movano Inc. (MOVE) Transaction Date: Jan 09, 2026 | Filing ID: 010715

Leabman Michael Aaron 🟡 adjusted position in 7.7K shares (1 derivative) of Movano Inc. (MOVE) at $7.34 Transaction Date: Jan 05, 2026 | Filing ID: 010713

Cogan Jeremy 🟡 adjusted position in 798 shares (1 derivative) of Movano Inc. (MOVE) at $8.35 Transaction Date: Jan 05, 2026 | Filing ID: 010712

Mastrocola Lauren 🟡 adjusted position in 10.9K shares (1 derivative) of Praxis Precision Medicines, Inc. (PRAX) at $294.38 ($2.3M) Transaction Date: Jan 08, 2026 | Filing ID: 000014

Sniecinski Megan 🟡 adjusted position in 16.2K shares (1 derivative) of Praxis Precision Medicines, Inc. (PRAX) at $294.38 ($2.6M) Transaction Date: Jan 08, 2026 | Filing ID: 000013

Nemiroff Alex 🟡 adjusted position in 11.5K shares (1 derivative) of Praxis Precision Medicines, Inc. (PRAX) at $294.38 ($1.9M) Transaction Date: Jan 08, 2026 | Filing ID: 000012

Kelly Timothy Edwin 🟡 adjusted position in 14.5K shares (1 derivative) of Praxis Precision Medicines, Inc. (PRAX) at $294.38 ($2.5M) Transaction Date: Jan 08, 2026 | Filing ID: 000011

Director Souza Marcio 🟡 adjusted position in 45.5K shares (1 derivative) of Praxis Precision Medicines, Inc. (PRAX) at $294.38 ($7.7M) Transaction Date: Jan 08, 2026 | Filing ID: 000010

New Form 3 - Praxis Precision Medicines, Inc. Filed: 2026-01-12 AccNo: 0001689548-26-000009 Size: 368 KB

New Form 3 - Praxis Precision Medicines, Inc. Filed: 2026-01-12 AccNo: 0001689548-26-000008 Size: 369 KB

Kline Kyle 🟡 adjusted position in 3.6K shares (1 derivative) of GLOBUS MEDICAL INC (GMED) at $101.10 Transaction Date: Jan 08, 2026 | Filing ID: 010699

📋 Daniel Bensen (Officer) plans to sell 8K shares of Tyra Biosciences, Inc (at $29.00 each, total $232K) Filed: Jan 12, 2026 | ID: 001882

Norwalk Leslie V 🔴 sold 2.0K shares of GLOBUS MEDICAL INC (GMED) at $101.10 Transaction Date: Jan 08, 2026 | Filing ID: 010697

Paravasthu Mukund 🔴 sold 2.1K shares of NovoCure Ltd (NVCR) at $14.35 Transaction Date: Jan 11, 2026 | Filing ID: 000002

Mirum Pharma - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)